img

Global Sumatriptan Succinate Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Sumatriptan Succinate Market Insights, Forecast to 2034

Sumatriptan is used to treat acute migraine headaches in adults. It is not used to prevent migraine headaches and is not used for cluster headaches. Sumatriptan works in the brain to relieve the pain from migraine headaches. It belongs to the group of medicines called triptans.
Global Sumatriptan Succinate market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Sumatriptan Succinate industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Sumatriptan Succinate key manufacturers include GlaxoSmithKline, Pfizer, Teva, Endo Pharmaceuticals, Mylan, Merck and Sun Pharmaceutical, etc. GlaxoSmithKline, Pfizer, Teva are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Sumatriptan Succinate were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Sumatriptan Succinate market and estimated to attract more attentions from industry insiders and investors.
Sumatriptan Succinate can be divided into Tablet, Subcutaneous Injection and Nasal Spray,, etc. Tablet is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Sumatriptan Succinate is widely used in various fields, such as Hospital Pharmacies and Drug Stores, etc. Hospital Pharmacies provides greatest supports to the Sumatriptan Succinate industry development. In 2022, global % sales of Sumatriptan Succinate went into Hospital Pharmacies filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Sumatriptan Succinate market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Sumatriptan Succinate market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GlaxoSmithKline
Pfizer
Teva
Endo Pharmaceuticals
Mylan
Merck
Sun Pharmaceutical
Segment by Type
Tablet
Subcutaneous Injection
Nasal Spray

Segment by Application


Hospital Pharmacies
Drug Stores

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Sumatriptan Succinate plant distribution, commercial date of Sumatriptan Succinate, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Sumatriptan Succinate introduction, etc. Sumatriptan Succinate Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Sumatriptan Succinate
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Sumatriptan Succinate Product Introduction
1.2 Market by Type
1.2.1 Global Sumatriptan Succinate Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Tablet
1.2.3 Subcutaneous Injection
1.2.4 Nasal Spray
1.3 Market by Application
1.3.1 Global Sumatriptan Succinate Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Sumatriptan Succinate Sales Estimates and Forecasts 2018-2029
2.2 Global Sumatriptan Succinate Revenue by Region
2.2.1 Global Sumatriptan Succinate Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Sumatriptan Succinate Revenue by Region (2018-2024)
2.2.3 Global Sumatriptan Succinate Revenue by Region (2024-2029)
2.2.4 Global Sumatriptan Succinate Revenue Market Share by Region (2018-2029)
2.3 Global Sumatriptan Succinate Sales Estimates and Forecasts 2018-2029
2.4 Global Sumatriptan Succinate Sales by Region
2.4.1 Global Sumatriptan Succinate Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Sumatriptan Succinate Sales by Region (2018-2024)
2.4.3 Global Sumatriptan Succinate Sales by Region (2024-2029)
2.4.4 Global Sumatriptan Succinate Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Sumatriptan Succinate Sales by Manufacturers
3.1.1 Global Sumatriptan Succinate Sales by Manufacturers (2018-2024)
3.1.2 Global Sumatriptan Succinate Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sumatriptan Succinate in 2022
3.2 Global Sumatriptan Succinate Revenue by Manufacturers
3.2.1 Global Sumatriptan Succinate Revenue by Manufacturers (2018-2024)
3.2.2 Global Sumatriptan Succinate Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Sumatriptan Succinate Revenue in 2022
3.3 Global Key Players of Sumatriptan Succinate, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Sumatriptan Succinate Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Sumatriptan Succinate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Sumatriptan Succinate, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Sumatriptan Succinate, Product Offered and Application
3.8 Global Key Manufacturers of Sumatriptan Succinate, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Sumatriptan Succinate Sales by Type
4.1.1 Global Sumatriptan Succinate Historical Sales by Type (2018-2024)
4.1.2 Global Sumatriptan Succinate Forecasted Sales by Type (2024-2029)
4.1.3 Global Sumatriptan Succinate Sales Market Share by Type (2018-2029)
4.2 Global Sumatriptan Succinate Revenue by Type
4.2.1 Global Sumatriptan Succinate Historical Revenue by Type (2018-2024)
4.2.2 Global Sumatriptan Succinate Forecasted Revenue by Type (2024-2029)
4.2.3 Global Sumatriptan Succinate Revenue Market Share by Type (2018-2029)
4.3 Global Sumatriptan Succinate Price by Type
4.3.1 Global Sumatriptan Succinate Price by Type (2018-2024)
4.3.2 Global Sumatriptan Succinate Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Sumatriptan Succinate Sales by Application
5.1.1 Global Sumatriptan Succinate Historical Sales by Application (2018-2024)
5.1.2 Global Sumatriptan Succinate Forecasted Sales by Application (2024-2029)
5.1.3 Global Sumatriptan Succinate Sales Market Share by Application (2018-2029)
5.2 Global Sumatriptan Succinate Revenue by Application
5.2.1 Global Sumatriptan Succinate Historical Revenue by Application (2018-2024)
5.2.2 Global Sumatriptan Succinate Forecasted Revenue by Application (2024-2029)
5.2.3 Global Sumatriptan Succinate Revenue Market Share by Application (2018-2029)
5.3 Global Sumatriptan Succinate Price by Application
5.3.1 Global Sumatriptan Succinate Price by Application (2018-2024)
5.3.2 Global Sumatriptan Succinate Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Sumatriptan Succinate Market Size by Type
6.1.1 US & Canada Sumatriptan Succinate Sales by Type (2018-2029)
6.1.2 US & Canada Sumatriptan Succinate Revenue by Type (2018-2029)
6.2 US & Canada Sumatriptan Succinate Market Size by Application
6.2.1 US & Canada Sumatriptan Succinate Sales by Application (2018-2029)
6.2.2 US & Canada Sumatriptan Succinate Revenue by Application (2018-2029)
6.3 US & Canada Sumatriptan Succinate Market Size by Country
6.3.1 US & Canada Sumatriptan Succinate Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Sumatriptan Succinate Sales by Country (2018-2029)
6.3.3 US & Canada Sumatriptan Succinate Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Sumatriptan Succinate Market Size by Type
7.1.1 Europe Sumatriptan Succinate Sales by Type (2018-2029)
7.1.2 Europe Sumatriptan Succinate Revenue by Type (2018-2029)
7.2 Europe Sumatriptan Succinate Market Size by Application
7.2.1 Europe Sumatriptan Succinate Sales by Application (2018-2029)
7.2.2 Europe Sumatriptan Succinate Revenue by Application (2018-2029)
7.3 Europe Sumatriptan Succinate Market Size by Country
7.3.1 Europe Sumatriptan Succinate Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Sumatriptan Succinate Sales by Country (2018-2029)
7.3.3 Europe Sumatriptan Succinate Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Sumatriptan Succinate Market Size
8.1.1 China Sumatriptan Succinate Sales (2018-2029)
8.1.2 China Sumatriptan Succinate Revenue (2018-2029)
8.2 China Sumatriptan Succinate Market Size by Application
8.2.1 China Sumatriptan Succinate Sales by Application (2018-2029)
8.2.2 China Sumatriptan Succinate Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Sumatriptan Succinate Market Size by Type
9.1.1 Asia Sumatriptan Succinate Sales by Type (2018-2029)
9.1.2 Asia Sumatriptan Succinate Revenue by Type (2018-2029)
9.2 Asia Sumatriptan Succinate Market Size by Application
9.2.1 Asia Sumatriptan Succinate Sales by Application (2018-2029)
9.2.2 Asia Sumatriptan Succinate Revenue by Application (2018-2029)
9.3 Asia Sumatriptan Succinate Sales by Region
9.3.1 Asia Sumatriptan Succinate Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Sumatriptan Succinate Revenue by Region (2018-2029)
9.3.3 Asia Sumatriptan Succinate Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Sumatriptan Succinate Market Size by Type
10.1.1 Middle East, Africa and Latin America Sumatriptan Succinate Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Sumatriptan Succinate Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Sumatriptan Succinate Market Size by Application
10.2.1 Middle East, Africa and Latin America Sumatriptan Succinate Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Sumatriptan Succinate Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Sumatriptan Succinate Sales by Country
10.3.1 Middle East, Africa and Latin America Sumatriptan Succinate Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Sumatriptan Succinate Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Sumatriptan Succinate Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Sumatriptan Succinate Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 GlaxoSmithKline Sumatriptan Succinate Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Sumatriptan Succinate Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Pfizer Sumatriptan Succinate Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Overview
11.3.3 Teva Sumatriptan Succinate Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Teva Sumatriptan Succinate Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Recent Developments
11.4 Endo Pharmaceuticals
11.4.1 Endo Pharmaceuticals Company Information
11.4.2 Endo Pharmaceuticals Overview
11.4.3 Endo Pharmaceuticals Sumatriptan Succinate Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Endo Pharmaceuticals Sumatriptan Succinate Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Endo Pharmaceuticals Recent Developments
11.5 Mylan
11.5.1 Mylan Company Information
11.5.2 Mylan Overview
11.5.3 Mylan Sumatriptan Succinate Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Mylan Sumatriptan Succinate Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mylan Recent Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Overview
11.6.3 Merck Sumatriptan Succinate Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Merck Sumatriptan Succinate Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merck Recent Developments
11.7 Sun Pharmaceutical
11.7.1 Sun Pharmaceutical Company Information
11.7.2 Sun Pharmaceutical Overview
11.7.3 Sun Pharmaceutical Sumatriptan Succinate Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Sun Pharmaceutical Sumatriptan Succinate Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sun Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Sumatriptan Succinate Industry Chain Analysis
12.2 Sumatriptan Succinate Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Sumatriptan Succinate Production Mode & Process
12.4 Sumatriptan Succinate Sales and Marketing
12.4.1 Sumatriptan Succinate Sales Channels
12.4.2 Sumatriptan Succinate Distributors
12.5 Sumatriptan Succinate Customers
13 Market Dynamics
13.1 Sumatriptan Succinate Industry Trends
13.2 Sumatriptan Succinate Market Drivers
13.3 Sumatriptan Succinate Market Challenges
13.4 Sumatriptan Succinate Market Restraints
14 Key Findings in The Global Sumatriptan Succinate Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Sumatriptan Succinate Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Tablet
Table 3. Major Manufacturers of Subcutaneous Injection
Table 4. Major Manufacturers of Nasal Spray
Table 5. Global Sumatriptan Succinate Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Sumatriptan Succinate Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Sumatriptan Succinate Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Sumatriptan Succinate Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Sumatriptan Succinate Revenue Market Share by Region (2018-2024)
Table 10. Global Sumatriptan Succinate Revenue Market Share by Region (2024-2029)
Table 11. Global Sumatriptan Succinate Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Sumatriptan Succinate Sales by Region (2018-2024) & (K Doses)
Table 13. Global Sumatriptan Succinate Sales by Region (2024-2029) & (K Doses)
Table 14. Global Sumatriptan Succinate Sales Market Share by Region (2018-2024)
Table 15. Global Sumatriptan Succinate Sales Market Share by Region (2024-2029)
Table 16. Global Sumatriptan Succinate Sales by Manufacturers (2018-2024) & (K Doses)
Table 17. Global Sumatriptan Succinate Sales Share by Manufacturers (2018-2024)
Table 18. Global Sumatriptan Succinate Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Sumatriptan Succinate Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Sumatriptan Succinate, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Sumatriptan Succinate Price by Manufacturers 2018-2024 (US$/Dose)
Table 22. Global Sumatriptan Succinate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Sumatriptan Succinate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sumatriptan Succinate as of 2022)
Table 24. Global Key Manufacturers of Sumatriptan Succinate, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Sumatriptan Succinate, Product Offered and Application
Table 26. Global Key Manufacturers of Sumatriptan Succinate, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Sumatriptan Succinate Sales by Type (2018-2024) & (K Doses)
Table 29. Global Sumatriptan Succinate Sales by Type (2024-2029) & (K Doses)
Table 30. Global Sumatriptan Succinate Sales Share by Type (2018-2024)
Table 31. Global Sumatriptan Succinate Sales Share by Type (2024-2029)
Table 32. Global Sumatriptan Succinate Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Sumatriptan Succinate Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Sumatriptan Succinate Revenue Share by Type (2018-2024)
Table 35. Global Sumatriptan Succinate Revenue Share by Type (2024-2029)
Table 36. Sumatriptan Succinate Price by Type (2018-2024) & (US$/Dose)
Table 37. Global Sumatriptan Succinate Price Forecast by Type (2024-2029) & (US$/Dose)
Table 38. Global Sumatriptan Succinate Sales by Application (2018-2024) & (K Doses)
Table 39. Global Sumatriptan Succinate Sales by Application (2024-2029) & (K Doses)
Table 40. Global Sumatriptan Succinate Sales Share by Application (2018-2024)
Table 41. Global Sumatriptan Succinate Sales Share by Application (2024-2029)
Table 42. Global Sumatriptan Succinate Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Sumatriptan Succinate Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Sumatriptan Succinate Revenue Share by Application (2018-2024)
Table 45. Global Sumatriptan Succinate Revenue Share by Application (2024-2029)
Table 46. Sumatriptan Succinate Price by Application (2018-2024) & (US$/Dose)
Table 47. Global Sumatriptan Succinate Price Forecast by Application (2024-2029) & (US$/Dose)
Table 48. US & Canada Sumatriptan Succinate Sales by Type (2018-2024) & (K Doses)
Table 49. US & Canada Sumatriptan Succinate Sales by Type (2024-2029) & (K Doses)
Table 50. US & Canada Sumatriptan Succinate Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Sumatriptan Succinate Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Sumatriptan Succinate Sales by Application (2018-2024) & (K Doses)
Table 53. US & Canada Sumatriptan Succinate Sales by Application (2024-2029) & (K Doses)
Table 54. US & Canada Sumatriptan Succinate Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Sumatriptan Succinate Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Sumatriptan Succinate Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Sumatriptan Succinate Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Sumatriptan Succinate Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Sumatriptan Succinate Sales by Country (2018-2024) & (K Doses)
Table 60. US & Canada Sumatriptan Succinate Sales by Country (2024-2029) & (K Doses)
Table 61. Europe Sumatriptan Succinate Sales by Type (2018-2024) & (K Doses)
Table 62. Europe Sumatriptan Succinate Sales by Type (2024-2029) & (K Doses)
Table 63. Europe Sumatriptan Succinate Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Sumatriptan Succinate Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Sumatriptan Succinate Sales by Application (2018-2024) & (K Doses)
Table 66. Europe Sumatriptan Succinate Sales by Application (2024-2029) & (K Doses)
Table 67. Europe Sumatriptan Succinate Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Sumatriptan Succinate Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Sumatriptan Succinate Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Sumatriptan Succinate Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Sumatriptan Succinate Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Sumatriptan Succinate Sales by Country (2018-2024) & (K Doses)
Table 73. Europe Sumatriptan Succinate Sales by Country (2024-2029) & (K Doses)
Table 74. China Sumatriptan Succinate Sales by Type (2018-2024) & (K Doses)
Table 75. China Sumatriptan Succinate Sales by Type (2024-2029) & (K Doses)
Table 76. China Sumatriptan Succinate Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Sumatriptan Succinate Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Sumatriptan Succinate Sales by Application (2018-2024) & (K Doses)
Table 79. China Sumatriptan Succinate Sales by Application (2024-2029) & (K Doses)
Table 80. China Sumatriptan Succinate Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Sumatriptan Succinate Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Sumatriptan Succinate Sales by Type (2018-2024) & (K Doses)
Table 83. Asia Sumatriptan Succinate Sales by Type (2024-2029) & (K Doses)
Table 84. Asia Sumatriptan Succinate Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Sumatriptan Succinate Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Sumatriptan Succinate Sales by Application (2018-2024) & (K Doses)
Table 87. Asia Sumatriptan Succinate Sales by Application (2024-2029) & (K Doses)
Table 88. Asia Sumatriptan Succinate Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Sumatriptan Succinate Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Sumatriptan Succinate Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Sumatriptan Succinate Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Sumatriptan Succinate Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Sumatriptan Succinate Sales by Region (2018-2024) & (K Doses)
Table 94. Asia Sumatriptan Succinate Sales by Region (2024-2029) & (K Doses)
Table 95. Middle East, Africa and Latin America Sumatriptan Succinate Sales by Type (2018-2024) & (K Doses)
Table 96. Middle East, Africa and Latin America Sumatriptan Succinate Sales by Type (2024-2029) & (K Doses)
Table 97. Middle East, Africa and Latin America Sumatriptan Succinate Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Sumatriptan Succinate Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Sumatriptan Succinate Sales by Application (2018-2024) & (K Doses)
Table 100. Middle East, Africa and Latin America Sumatriptan Succinate Sales by Application (2024-2029) & (K Doses)
Table 101. Middle East, Africa and Latin America Sumatriptan Succinate Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Sumatriptan Succinate Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Sumatriptan Succinate Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Sumatriptan Succinate Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Sumatriptan Succinate Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Sumatriptan Succinate Sales by Country (2018-2024) & (K Doses)
Table 107. Middle East, Africa and Latin America Sumatriptan Succinate Sales by Country (2024-2029) & (K Doses)
Table 108. GlaxoSmithKline Company Information
Table 109. GlaxoSmithKline Description and Major Businesses
Table 110. GlaxoSmithKline Sumatriptan Succinate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 111. GlaxoSmithKline Sumatriptan Succinate Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. GlaxoSmithKline Recent Developments
Table 113. Pfizer Company Information
Table 114. Pfizer Description and Major Businesses
Table 115. Pfizer Sumatriptan Succinate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 116. Pfizer Sumatriptan Succinate Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Pfizer Recent Developments
Table 118. Teva Company Information
Table 119. Teva Description and Major Businesses
Table 120. Teva Sumatriptan Succinate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 121. Teva Sumatriptan Succinate Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Teva Recent Developments
Table 123. Endo Pharmaceuticals Company Information
Table 124. Endo Pharmaceuticals Description and Major Businesses
Table 125. Endo Pharmaceuticals Sumatriptan Succinate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 126. Endo Pharmaceuticals Sumatriptan Succinate Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Endo Pharmaceuticals Recent Developments
Table 128. Mylan Company Information
Table 129. Mylan Description and Major Businesses
Table 130. Mylan Sumatriptan Succinate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 131. Mylan Sumatriptan Succinate Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Mylan Recent Developments
Table 133. Merck Company Information
Table 134. Merck Description and Major Businesses
Table 135. Merck Sumatriptan Succinate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 136. Merck Sumatriptan Succinate Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Merck Recent Developments
Table 138. Sun Pharmaceutical Company Information
Table 139. Sun Pharmaceutical Description and Major Businesses
Table 140. Sun Pharmaceutical Sumatriptan Succinate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 141. Sun Pharmaceutical Sumatriptan Succinate Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Sun Pharmaceutical Recent Developments
Table 143. Key Raw Materials Lists
Table 144. Raw Materials Key Suppliers Lists
Table 145. Sumatriptan Succinate Distributors List
Table 146. Sumatriptan Succinate Customers List
Table 147. Sumatriptan Succinate Market Trends
Table 148. Sumatriptan Succinate Market Drivers
Table 149. Sumatriptan Succinate Market Challenges
Table 150. Sumatriptan Succinate Market Restraints
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Sumatriptan Succinate Product Picture
Figure 2. Global Sumatriptan Succinate Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Sumatriptan Succinate Market Share by Type in 2022 & 2029
Figure 4. Tablet Product Picture
Figure 5. Subcutaneous Injection Product Picture
Figure 6. Nasal Spray Product Picture
Figure 7. Global Sumatriptan Succinate Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Sumatriptan Succinate Market Share by Application in 2022 & 2029
Figure 9. Hospital Pharmacies
Figure 10. Drug Stores
Figure 11. Sumatriptan Succinate Report Years Considered
Figure 12. Global Sumatriptan Succinate Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Sumatriptan Succinate Revenue 2018-2029 (US$ Million)
Figure 14. Global Sumatriptan Succinate Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Sumatriptan Succinate Revenue Market Share by Region (2018-2029)
Figure 16. Global Sumatriptan Succinate Sales 2018-2029 ((K Doses)
Figure 17. Global Sumatriptan Succinate Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Sumatriptan Succinate Sales YoY (2018-2029) & (K Doses)
Figure 19. US & Canada Sumatriptan Succinate Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Sumatriptan Succinate Sales YoY (2018-2029) & (K Doses)
Figure 21. Europe Sumatriptan Succinate Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Sumatriptan Succinate Sales YoY (2018-2029) & (K Doses)
Figure 23. China Sumatriptan Succinate Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Sumatriptan Succinate Sales YoY (2018-2029) & (K Doses)
Figure 25. Asia (excluding China) Sumatriptan Succinate Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Sumatriptan Succinate Sales YoY (2018-2029) & (K Doses)
Figure 27. Middle East, Africa and Latin America Sumatriptan Succinate Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Sumatriptan Succinate Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Sumatriptan Succinate in the World: Market Share by Sumatriptan Succinate Revenue in 2022
Figure 30. Global Sumatriptan Succinate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Sumatriptan Succinate Sales Market Share by Type (2018-2029)
Figure 32. Global Sumatriptan Succinate Revenue Market Share by Type (2018-2029)
Figure 33. Global Sumatriptan Succinate Sales Market Share by Application (2018-2029)
Figure 34. Global Sumatriptan Succinate Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Sumatriptan Succinate Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Sumatriptan Succinate Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Sumatriptan Succinate Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Sumatriptan Succinate Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Sumatriptan Succinate Revenue Share by Country (2018-2029)
Figure 40. US & Canada Sumatriptan Succinate Sales Share by Country (2018-2029)
Figure 41. U.S. Sumatriptan Succinate Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Sumatriptan Succinate Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Sumatriptan Succinate Sales Market Share by Type (2018-2029)
Figure 44. Europe Sumatriptan Succinate Revenue Market Share by Type (2018-2029)
Figure 45. Europe Sumatriptan Succinate Sales Market Share by Application (2018-2029)
Figure 46. Europe Sumatriptan Succinate Revenue Market Share by Application (2018-2029)
Figure 47. Europe Sumatriptan Succinate Revenue Share by Country (2018-2029)
Figure 48. Europe Sumatriptan Succinate Sales Share by Country (2018-2029)
Figure 49. Germany Sumatriptan Succinate Revenue (2018-2029) & (US$ Million)
Figure 50. France Sumatriptan Succinate Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Sumatriptan Succinate Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Sumatriptan Succinate Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Sumatriptan Succinate Revenue (2018-2029) & (US$ Million)
Figure 54. China Sumatriptan Succinate Sales Market Share by Type (2018-2029)
Figure 55. China Sumatriptan Succinate Revenue Market Share by Type (2018-2029)
Figure 56. China Sumatriptan Succinate Sales Market Share by Application (2018-2029)
Figure 57. China Sumatriptan Succinate Revenue Market Share by Application (2018-2029)
Figure 58. Asia Sumatriptan Succinate Sales Market Share by Type (2018-2029)
Figure 59. Asia Sumatriptan Succinate Revenue Market Share by Type (2018-2029)
Figure 60. Asia Sumatriptan Succinate Sales Market Share by Application (2018-2029)
Figure 61. Asia Sumatriptan Succinate Revenue Market Share by Application (2018-2029)
Figure 62. Asia Sumatriptan Succinate Revenue Share by Region (2018-2029)
Figure 63. Asia Sumatriptan Succinate Sales Share by Region (2018-2029)
Figure 64. Japan Sumatriptan Succinate Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Sumatriptan Succinate Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Sumatriptan Succinate Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Sumatriptan Succinate Revenue (2018-2029) & (US$ Million)
Figure 68. India Sumatriptan Succinate Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Sumatriptan Succinate Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Sumatriptan Succinate Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Sumatriptan Succinate Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Sumatriptan Succinate Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Sumatriptan Succinate Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Sumatriptan Succinate Sales Share by Country (2018-2029)
Figure 75. Brazil Sumatriptan Succinate Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Sumatriptan Succinate Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Sumatriptan Succinate Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Sumatriptan Succinate Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Sumatriptan Succinate Revenue (2018-2029) & (US$ Million)
Figure 80. Sumatriptan Succinate Value Chain
Figure 81. Sumatriptan Succinate Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries